Table 2.
References | |
---|---|
Endothelial dysfunction | |
cbs+/− | |
Aortic and mesenteric arteriolar endothelial dysfunction | 40, 174 |
cbs−/− | |
Cremasteric artery and aortic endothelial dysfunction | 74 |
Vascular remodeling | |
cbs+/− | |
Aortic hypertrophy | 123 |
Increased carotid artery neointima formation* | 152 |
Increased aortic stiffness* | 150 |
Increased carotid artery permeability* | 150 |
Accelerated carotid artery thrombosis* | 32 |
Mild left ventricular hypertrophy* | 94 |
Impaired angiogenesis | |
cbs+/− | |
Impaired angiogenesis after hindlimb ischemia | 16 |
Decreased carotid artery reendothelialization* | 152 |
Dyslipidosis, thrombosis, and arteriosclerosis | |
cbs−/− | |
Abnormal lipid metabolism | 119 |
Increased triglycerides and nonesterified fatty acids | |
Decreased thiolase activity | |
Decreased hepatic ApoB100 | |
Increased serum ApoB100 and VLDL | |
Decreased cholesterol/phospholipid in HDL-cholesterol but not total cholesterol | |
Decreased lecithin-cholesterol acyltransferase activity | |
Decreased liver paraoxonase 1 activity | |
Differential expression of ATP-binding cassette transporters and genes involved in liver lipid homeostasis | 51, 53 |
Reduced levels of the hepatocyte antiapoptotic factor DYRK1A | 55 |
Redox disequilibrium in the liver, although attenuated by increased catalase activity | 56 |
cbs−/−Cbs+/− | |
Rescued hepatic steatosis and neonatal lethality of cbs−/− without lowering [Hcy] or rescuing hypercoagulability | 104 |
cbs+/− | |
Normal hepatic and plasma triglycerides, normal plasma cholesterol, and 44% greater hepatic cholesterol than cbs+/+ | 176 |
Tg-S466L cbs−/− | |
Monocytosis and enhanced plaque formation | 183 |
cbs+/−ApoE−/− | |
Increased thrombosis | 32, 178 |
cbs+/−ApoA1+/− | |
Hypertension and left ventricular hypertrophy | 20, 21 |
Cerebrovascular dysfunction | |
cbs+/− | |
Cerebral arteriolar remodeling | 12 |
Altered blood-brain barrier in permeability* | 77 |
cbs is the murine CBS gene and Cbs is the human CBS gene; thus, cbs−/− Cbs+/− mice are cbs−/− mice with heterozygous Cbs gene expression. Apo, apolipoprotein; Hcy, homocysteine.
With concomitant diet-induced hyperhomocysteinemia.